Hubei Goto Biopharm Group Co., Ltd.

¥24.72As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300966Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (15.95%)
Div yield 0.18%
ROE (11.05%)
Biotechnology
Beta (5Y) 0.67
PE TTM —
TSR TTM 10.78%
Mkt cap ¥2.823B
ROIC (3.10%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥32
29.49%
(94.47%)
Hold 7|8|2|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.37
0.39
0.43
0.45
9.32%
13.44%
23.99%
28.05%
Revenue¥M
215.4
211.2
206.1
206.3
3.80%
1.39%
(2.22%)
(2.67%)
Peers (US$423.2M)
Cap (US$)
PE
423.0M
—
Capital
TTM
5Y
10Y
Leveragex
0.743
0.207
0.195
EBIT/Intx
2.368
0.680
0.624
Own earn%
(5.48)
(10.74)
(6.07)
Sh yield%
44.62
21.60
22.58
Owners
Insiders/Inst%
7.52
56.67
Short interest%
1.40
SBC / revenue%
0.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
0–6
$1 testx
0.1
Incr. ROIC%
9